Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Desager

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Pharmacology|January 1, 1988
Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjectsR Hulhoven, J P Desager, S Cox, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosinJ P Desager, C Harvengt, G Bianchetti, et al.
European Journal of Cancer|October 1, 1977
Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: a preliminary reportR Hulhoven, J P Desager, G Sokai, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Beta-blocking agents and plasma lipids: an updateC Harvengt, J P Desager, F Heller, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1993
The vitamin A fat-loading test in young normolipidemic subjectsF R Heller, C Vandenplas, J P Desager, et al.
Annals of Clinical Biochemistry|December 10, 1999
Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity?F Heller, O Descamps, J C Hondekijn, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
An improvement of Barter's method for assaying plasma cholesterol ester transfer activity: experimental and clinical applicationsC Harvengt, J P Desager, P Mailleux, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Prevalence of drug hydroxylator phenotypes in BelgiumV Leclercq, J P Desager, Y van Nieuwenhuyze, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1984
Ritodrine serum levels: influence of dose and route of administrationM Van Lierde, J P Desager, C Harvengt, et al.
The Journal of International Medical Research|November 1, 1989
Oral bioavailability of ampicillin and amoxycillin alone and bound in fixed proportions to sulbactam and clavulanic acidJ P Desager, J Costermans, Y Van Nieuwenhuyze, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|January 1, 1988
Influence of repeated administration of cimetidine on the pharmacokinetics and pharmacodynamics of adinazolam in healthy subjectsR Hulhoven, J P Desager, S Cox, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1993
The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosinJ P Desager, C Harvengt, G Bianchetti, et al.
European Journal of Cancer|October 1, 1977
Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: a preliminary reportR Hulhoven, J P Desager, G Sokai, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Beta-blocking agents and plasma lipids: an updateC Harvengt, J P Desager, F Heller, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 1993
The vitamin A fat-loading test in young normolipidemic subjectsF R Heller, C Vandenplas, J P Desager, et al.
Annals of Clinical Biochemistry|December 10, 1999
Atorvastatin and low-density lipoprotein subfractions profile in mixed hyperlipidaemia: a contributory effect of reduced hepatic lipase activity?F Heller, O Descamps, J C Hondekijn, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
An improvement of Barter's method for assaying plasma cholesterol ester transfer activity: experimental and clinical applicationsC Harvengt, J P Desager, P Mailleux, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Prevalence of drug hydroxylator phenotypes in BelgiumV Leclercq, J P Desager, Y van Nieuwenhuyze, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1984
Ritodrine serum levels: influence of dose and route of administrationM Van Lierde, J P Desager, C Harvengt, et al.
The Journal of International Medical Research|November 1, 1989
Oral bioavailability of ampicillin and amoxycillin alone and bound in fixed proportions to sulbactam and clavulanic acidJ P Desager, J Costermans, Y Van Nieuwenhuyze, et al.
Pageof 11